Coping with the Disfigurement of Scleroderma: Facial, Skin, and Hand Changes
Changes in appearance are a common and distressing aspect of scleroderma. Disfigurement in scleroderma often occurs in areas of the body that are both visible and socially relevant (e.g., face, hands), which can contribute to increased social anxiety and avoidance. A case study is provided to share examples of common concerns and challenges associated with treating patients with scleroderma who are experiencing body image distress; social, self-esteem, mood, and sexual impacts of body image distress are also discussed.The presence of significant body image is not always associated with severity of appearance changes, and open communication around changes in appearance is important. Referrals to mental health professionals should be initiated as appropriate.
KeywordsBody image Distress Appearance changes Disfigurement Quality of life Interventions
- 7.Jewett LR, Hudson M, Haythornthwaite JA, Heinberg L, Wigley FM, Baron M, Thombs BD. Canadian Scleroderma Research Group. Development and validation of the Brief-Satisfaction with Appearance Scale (Brief-SWAP) for systemic sclerosis (SSc). Arthritis Care Res. 2010;62(12):1779–86.CrossRefGoogle Scholar
- 9.Mills SD, Fox RS, Merz EL, Clements PJ, Kafaja S, Malcarne VL, Furst DE, Khanna D. Evaluation of the satisfaction with appearance scale and its short form in systemic sclerosis: analysis from the UCLA scleroderma quality of life study. J Rheumatol. 2015;Google Scholar
- 10.Seibold J, Harris ED, Budd RC, Genovese MC, Sergent JS. Kelley’s textbook of rheumatology. Philadelphia: Elsevier; 2007.Google Scholar
- 13.Robinson E. Psychological research on visible differences in adults. In: Lansdown R, Rumsey N, Bradbury E, Carr T, Partridge J, editors. Visibly different: coping with disfigurement. London: Butterworth; 1997. p. 102–11.Google Scholar
- 15.Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger Jr TA, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE. Skin thickness scores as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum. 2000;43(11):2445–54.CrossRefPubMedGoogle Scholar
- 20.Macgregor F. After plastic surgery: adaptation and adjustment. New York: Praeger; 1979.Google Scholar
- 21.Bradbury E. Understanding the problems. In: Lansdown R, Rumsey N, Bradbury E, Carr A, Partridge J, editors. Visibly different: coping with disfigurement. Oxford: Butterworth-Heinemann; 1997. p. 180–93.Google Scholar
- 31.Schover LR, Jensen SR. Sexuality and chronic illness: a comprehensive approach. New York: Guilford; 1988.Google Scholar
- 41.Murray AK, Moore TL, Richards H, Ennis H, Grif ths CEM, 822 Herrick AL. Pilot study of intense pulsed light for the treatment of 823 systemic sclerosis‐related telangiectases. Br J Dermatol. 2012; 824 167(3):563–9.Google Scholar
- 43.Spackman GK. Scleroderma: what the general dentist should know. Gen Dent. 1999;47(6):576–9.Google Scholar
- 45.Sundriyal D, Kumar N, Chandrasekharan A, Gadpayle AK. Mauskopf facies. Brit Med J Case Rep [Internet]. 2013: available from: http://casereports.bmj.com/content/2013/bcr-2013-200163.full.pdf+html.